Cirrose por HCV genótipo 1a, tratada com 7 semanas de interferon peguilado/ribavirina, transplantada por hepatocarcinoma, em RVS / Cirrhosis by HCV genotype 1a, treated with 7 weeks of pegylated interferon/ribavirin, transplanted for hepatocellular carcinoma, on SVR
GED gastroenterol. endosc. dig
;
35(1): 28-31, jan.-mar. 2016.
Article
in Portuguese
| LILACS
| ID: lil-784379
RESUMO
A hepatopatia crônica causada pelo vírus da hepatite C (HCV) é a indicação mais comum de transplante hepático no mundo. A recorrência da hepatite C após o transplante hepático é elevada e em grande parte dos pacientes pode evoluir com cirrose e perda do enxerto de forma acelerada. Relatamos caso de portadora de cirrose por hepatite C genótipo 1a, tratada durante sete semanas com Interferon Peguilado e Ribavirina, em Resposta Viral Sustentada (RVS), mesmo após transplante hepático por hepatocarcinoma.
ABSTRACT
Chronic liver disease caused by hepatitis C virus (HCV) is the most common indication for liver transplantation in the world. The recurrence of hepatitis C after liver transplantation is high and most patients can develop cirrhosis and graft loss in an accelerated manner. A case of a patient with cirrhosis due to hepatitis C genotype 1a, treated for seven weeks with pegylated interferon and Ribavirin in Sustained Viral Response (SVR), even after liver transplantation for hepatocellular carcinoma.
Full text:
Available
Index:
LILACS (Americas)
Main subject:
Ribavirin
/
Liver Transplantation
/
Interferon-alpha
/
Carcinoma, Hepatocellular
/
Hepatitis C, Chronic
/
Sustained Virologic Response
/
Liver Cirrhosis
Limits:
Aged
/
Female
/
Humans
Language:
Portuguese
Journal:
GED gastroenterol. endosc. dig
Journal subject:
Gastroenterology
Year:
2016
Type:
Article
Affiliation country:
Brazil
Institution/Affiliation country:
Universidade Federal do Triângulo Mineiro/BR
Similar
MEDLINE
...
LILACS
LIS